RuvC (an endonuclease) cleaves Holliday junctions.
| Inventor | Institute |
|---|---|
| Stephen West | Cancer Research UK, London Research Institute: Clare Hall Laboratories |
| Cat. #: | 151059 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Genetics |
| Application: | ELISA ; RIA ; WB |
| Target: | RuvC |
| Reactivity: | E.coli |
| Clone: | RuvC 5G9/3 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | RuvC (an endonuclease) cleaves Holliday junctions. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG2b |
| Molecular weight: | 79 kDa |
| Immunogen: | Ruv C protein from E. Coli. |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | RuvC (an endonuclease) cleaves Holliday junctions. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Davies et al. 1998. Curr Biol. 8(12):725-7. PMID: 9637927. Formation of RuvABC-Holliday junction complexes in vitro. Eggleston et al. 1997. Cell. 89(4):607-17. PMID: 9160752. In vitro reconstitution of the late steps of genetic recombination in E. coli. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.